Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-20-000749
Filing Date
2020-09-23
Accepted
2020-09-23 17:04:50
Documents
1
Period of Report
2020-09-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7846
  Complete submission text file 0000947871-20-000749.txt   9189
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address
Naschitz Anat (Reporting) CIK: 0001792060 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39122 | Film No.: 201192621